Difference between revisions of "Mannitol"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "==General information== Class/mechanism: Osmotic agent; increases circulating plasma volume <br>Route: IV <br>Extravasation: unknown For conciseness and simplicity, HemOnc.or...")
 
m
Line 8: Line 8:
 
==Diseases for which it is used==
 
==Diseases for which it is used==
 
''No known antineoplastic properties. Used for maintenance of plasma volume in certain chemotherapy protocols.''
 
''No known antineoplastic properties. Used for maintenance of plasma volume in certain chemotherapy protocols.''
 +
 +
[[Category:Drug index]]
 +
[[Category:Chemotherapy protective agents]]
 +
[[Category:Drugs FDA approved in 1965]]

Revision as of 17:00, 4 November 2014

General information

Class/mechanism: Osmotic agent; increases circulating plasma volume
Route: IV
Extravasation: unknown

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.

Diseases for which it is used

No known antineoplastic properties. Used for maintenance of plasma volume in certain chemotherapy protocols.